Dr. Mingchen Ba 巴明臣
Chief Physician, Associate Professor
Hepatobiliary and Pancreatic Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of malignant tumors of the breast, gastrointestinal tract, liver, gallbladder, pancreas, and retroperitoneum. Specializes in managing ascites and peritoneal effusion caused by abdominal malignancies.
Dr. Ba holds a PhD in surgical oncology and completed postdoctoral training at Nanfang Hospital, Southern Medical University, in 2005. Previously earned degrees from West China University of Medical Sciences (1997) and Sun Yat-sen University of Medical Sciences (2002). Focuses on molecular biology, gene diagnosis, and targeted therapy for malignancies. Authored over 100 papers and co-edited several medical textbooks.
Name order: in Chinese the family name comes first (Ba Mingchen). Papers usually list the name as Mingchen Ba or Ba M.
Selected publications
23 papers on PubMed matched by name and affiliation; 16 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2021 (first author): Safety and Effectiveness of High-Precision Hyperthermic Intraperitoneal Perfusion Chemotherapy in Peritoneal Carcinomatosis: A Real-World Study. PubMed 34422631
- Aging (Albany NY), 2021 (first author): Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis. PubMed 34226297
- Medicine (Baltimore), 2020 (first author): Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study. PubMed 32872001
- Surg Laparosc Endosc Percutan Tech, 2020 (first author): Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer. PubMed 32004214
- Cell Death Dis, 2020 (first author): LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression. PubMed 31988283
- BMC Urol, 2019 (first author): Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study. PubMed 31795980
- Onco Targets Ther, 2019 (first author): Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression. PubMed 31496731
- Oncol Lett, 2019 (first author): Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy. PubMed 31423274
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion